Standout Papers

BI 2536, a Potent and Selective Inhibitor of Polo-like Kinase 1, Inhibits Tumor Growth In Vivo... 2007 2026 2013 2019 683
  1. BI 2536, a Potent and Selective Inhibitor of Polo-like Kinase 1, Inhibits Tumor Growth In Vivo (2007)
    Martin Steegmaier, Matthias Hoffmann et al. Current Biology
  2. The Small-Molecule Inhibitor BI 2536 Reveals Novel Insights into Mitotic Roles of Polo-like Kinase 1 (2007)
    Péter Lénárt, Mark Petronczki et al. Current Biology

Immediate Impact

2 by Nobel laureates 33 from Science/Nature 66 standout
Sub-graph 1 of 21

Citing Papers

Structural mechanisms for regulation of GSDMB pore-forming activity
2023 StandoutNature
CDK4 and CDK6 kinases: From basic science to cancer therapy
2022 StandoutScience
16 intermediate papers

Works of Matthias Hoffmann being referenced

BI 6727, A Polo-like Kinase Inhibitor with Improved Pharmacokinetic Profile and Broad Antitumor Activity
2009
BI 2536, a Potent and Selective Inhibitor of Polo-like Kinase 1, Inhibits Tumor Growth In Vivo
2007 Standout
and 2 more

Author Peers

Author Last Decade Papers Cites
Matthias Hoffmann 1460 1110 626 11 1.9k
William R. Brinkley 1145 905 530 20 1.7k
Kara M. Hoar 1060 868 769 17 1.6k
Seth Sadis 2013 721 749 15 2.8k
Madhavi Bandi 1211 737 728 20 1.9k
Han-kuei Huang 2037 556 638 9 2.4k
Robert Toso 1062 760 657 9 1.9k
Karen E. Gascoigne 2063 1289 653 20 2.5k
Rebecca Ellston 1132 935 517 15 1.5k
Henning F. Horn 2169 901 1015 24 2.6k
Kirsten Mundt 1300 837 692 27 1.8k

All Works

Loading papers...

Rankless by CCL
2026